These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3067385)

  • 21. [Clinical evaluation of the action of vasoactive preparations by a functional polymetric method].
    Dmitrieva NV; Avakian GN; Iakovlev IuV; Nizhniĭ SV
    Klin Med (Mosk); 1985 Dec; 63(12):89-94. PubMed ID: 3912610
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of the individual changes in cardiovascular system reactivity in prescribing adrenergic blockaders].
    Paleev NR; Kaevitser IM; Kublanov LA
    Kardiologiia; 1977 Nov; 17(11):103-8. PubMed ID: 23449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The differential treatment of patients with neurocirculatory dystonia depending on the type of hemodynamic disorders].
    Tatarintsev AN; Dvorkin AI; Semchenko VM
    Ter Arkh; 1993; 65(11):72-4. PubMed ID: 8108807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of beta adrenergic receptor blockaders studied with propranolol on the ventricular repolarizzation in patients with hypertensive heart disease and chronic coronary insufficiency].
    Zani D; Melara D
    Cardiol Prat; 1969 Jun; 20(3):211-27. PubMed ID: 5407605
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thin layer chromatographic determination of talinolol, propranolol and triamterene in urine: compliance evaluation of hypertensive patients].
    Molling J; Leuschner U; Meyer FP; Walther H
    Pharmazie; 1986 Apr; 41(4):301-2. PubMed ID: 2873599
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
    Erina EV; Charyev KhE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):26-34. PubMed ID: 6139117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of beta-receptor blocking agents propranolol and practolol on ST-T changes in neurocirculatory asthenia.
    Wolf E; Braun K; Stern S
    Br Heart J; 1974 Sep; 36(9):872-9. PubMed ID: 4425601
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative study with Tobanum and Visken in hypertensive patients.
    Torma Z; Grubic V; Unyi G
    Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of a new psychopharmacological agent in cardiology].
    Ryba D; Halpern S
    Minerva Cardioangiol; 1971 Mar; 19(3):172-7. PubMed ID: 5573133
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison of the hemodynamic effects of Corinfar in patients with neurocirculatory dystonia and hypertensive disease].
    Goloshchapov OA; Goldabin VI; Rud' SS; Mashin AA; Geller AL
    Kardiologiia; 1992 Feb; 32(2):35-6. PubMed ID: 1527932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of essential arterial hypertension in workers in a metal-mechanic factory. Effects of long-term therapy with a beta-1 blocker].
    Fogari R; Orlandi C; Rogledi D; Finardi G
    G Ital Med Lav; 1982; 4(4-5):221-4. PubMed ID: 7185640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperkinetic beta-adrenergic circulatory state].
    Hayashi T; Fujimura H; Yamanaka T; Takabatake Y
    Nihon Rinsho; 1992 May; 50 Suppl():477-82. PubMed ID: 1324998
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of noise and acetone on the body of female workers of acetate and polyvinyl chloride fiber plants].
    Britanov NG
    Gig Tr Prof Zabol; 1979 Dec; (12):15-9. PubMed ID: 544321
    [No Abstract]   [Full Text] [Related]  

  • 34. [Trimepranol and propranolol (author's transl)].
    Kuchar L; Jedlicka K
    Cas Lek Cesk; 1973 Sep; 112(38):1181-2. PubMed ID: 4148031
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 36. White coat hypertension--do we need ambulatory blood pressure monitoring to manage hypertensive patients?
    Miller ST
    J Tenn Med Assoc; 1988 Sep; 81(9):569-74. PubMed ID: 3184944
    [No Abstract]   [Full Text] [Related]  

  • 37. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurocirculatory asthenia: psychoautonomic features and treatment possibilities].
    Frolova NL; Chutko LS; Surushkina SIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):51-4. PubMed ID: 23388593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular changes produced by some hemodynamic forces in neurocirculatory asthenia].
    Zamfirescu NR; Ciplea A; Bubuianu G; Drăgulescu N; Baltă N; Petrea S
    Fiziol Norm Patol; 1973; 19(3):207-20. PubMed ID: 4711534
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the problem of the etiology and clinical course of neurocirculatory dystonia of the hypertensive type].
    Ivakhnenko AG
    Voen Med Zh; 1969 Jan; 1():28-32. PubMed ID: 5766204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.